Abacus Life, Inc. (ABL)
NASDAQ: ABL · Real-Time Price · USD
8.86
+0.43 (5.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
Abacus Life Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3.15 | 1 | 1.47 | 1.08 | 1.22 |
Other Revenue | 99.26 | 65.4 | 43.24 | 0.12 | - |
Revenue | 102.41 | 66.4 | 44.71 | 1.2 | 1.22 |
Revenue Growth (YoY) | 77.68% | 48.50% | 3626.17% | -2.02% | - |
Cost of Revenue | 9.31 | 6.49 | 5.88 | 0.74 | 0.51 |
Gross Profit | 93.09 | 59.91 | 38.83 | 0.46 | 0.71 |
Selling, General & Admin | 65.21 | 31.39 | 4.02 | 0.1 | 0.05 |
Other Operating Expenses | - | - | - | 0.01 | - |
Operating Expenses | 72.1 | 34.8 | 4.03 | 0.12 | 0.05 |
Operating Income | 21 | 25.11 | 34.8 | 0.35 | 0.66 |
Interest Expense | -18.66 | -9.87 | -0.04 | - | - |
Interest & Investment Income | 2.19 | 0.59 | 0 | - | - |
Other Non Operating Income (Expenses) | -11.76 | -4.35 | -0.35 | - | - |
EBT Excluding Unusual Items | -7.23 | 11.49 | 34.41 | 0.35 | 0.66 |
Gain (Loss) on Sale of Investments | 2.95 | 1.37 | -1.05 | - | - |
Other Unusual Items | -6.08 | -2.36 | -0.09 | -0.48 | - |
Pretax Income | -10.36 | 10.5 | 33.28 | -0.13 | 0.66 |
Income Tax Expense | 1.91 | 1.47 | 0.89 | - | - |
Earnings From Continuing Operations | -12.27 | 9.03 | 32.39 | -0.13 | 0.66 |
Minority Interest in Earnings | 0.35 | 0.48 | -0.7 | 0.15 | - |
Net Income | -11.93 | 9.52 | 31.68 | 0.01 | 0.66 |
Net Income to Common | -11.93 | 9.52 | 31.68 | 0.01 | 0.66 |
Net Income Growth | - | -69.96% | 217707.47% | -97.80% | - |
Shares Outstanding (Basic) | 66 | 57 | 50 | - | - |
Shares Outstanding (Diluted) | 66 | 58 | 50 | - | - |
Shares Change (YoY) | 23.61% | 14.69% | - | - | - |
EPS (Basic) | -0.18 | 0.17 | 0.63 | - | - |
EPS (Diluted) | -0.19 | 0.16 | 0.63 | - | - |
EPS Growth | - | -74.56% | - | - | - |
Free Cash Flow | -131.8 | -64.71 | 10.69 | -0.16 | 0.65 |
Free Cash Flow Per Share | -1.99 | -1.12 | 0.21 | - | - |
Gross Margin | 90.90% | 90.23% | 86.84% | 38.67% | 57.98% |
Operating Margin | 20.50% | 37.82% | 77.83% | 28.91% | 54.06% |
Profit Margin | -11.65% | 14.33% | 70.86% | 1.21% | 54.06% |
Free Cash Flow Margin | -128.71% | -97.46% | 23.92% | -13.71% | 53.09% |
EBITDA | 27.89 | 28.52 | 34.81 | 0.35 | - |
EBITDA Margin | 27.23% | 42.95% | 77.84% | 29.12% | - |
D&A For EBITDA | 6.89 | 3.41 | 0 | 0 | - |
EBIT | 21 | 25.11 | 34.8 | 0.35 | 0.66 |
EBIT Margin | 20.50% | 37.82% | 77.83% | 28.91% | 54.06% |
Effective Tax Rate | - | 13.98% | 2.67% | - | - |
Revenue as Reported | 102.41 | 66.4 | 44.71 | 1.2 | 1.22 |
Source: S&P Capital IQ. Standard template. Financial Sources.